– USA, CA – PathogenX, the Carmel-based medical device company today announced the appointment of CEO Chuck Berkeley to the additional role of Chairman of the Board of Directors.
About Chuck Berkeley
Chuck Berkeley has spent the last 10 of his 20-year sales and management career in the medical device and healthcare technology sector. Before his current role as co-founder and CEO for Cypress Holdings Group, Inc, the parent company of PathogenX, Berkeley founded medical device distributorship Grey Medical, LLC in 2015.
Outside of the medical device innovation world, Berkeley has also made a name for himself as a world-class athlete. He competed in the 2010 Olympic Games as a bobsledder and has won multiple World Cup and Americas Cup gold and silver medals in the two-man and four-man bobsled.
His passion for game-changing solutions to wide-spread medical challenges led him to PathogenX. The company develops, manufactures, and distributes the PX2, a proprietary technology designed to dramatically simplify the process of medical waste disposal. The unique, double-batch, on-site sterilization device, about the size of a laser printer, safely and efficiently renders regulated medical waste (such as sharps) completely sterile, unrecognizable, and non-reusable in compliance with all federal EPA, CDC, and OSHA standards and guidelines. Each PX2 device is capable of processing up to 10 gallons of medical waste per day.
About PathogenX
The mission of PathogenX, Inc. is to reimagine and change the way nearly one million U.S. low-volume generators manage their infectious waste by offering an economic, efficient, and environmentally safe solution, which also serves to eliminate liability.
For more information: https://pathogenx.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
